Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.37 USD
Change Today +0.11 / 1.33%
Volume 545.5K
INO On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 1:07 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Simon X. Benito

Director, Chairman of Audit Committee and Member of Compensation Committee, Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 2 different industries.

See Board Relationships
69$144,835

Background*

Mr. Simon X. Benito held various positions at Merck & Co Inc. From 1974 to 1999, including Senior Vice President, Vaccine Division from 1996 to 1999 and Vice President of Merck Human Health, Japan from 1986 to 1993. Mr. Benito served as Executive Vice President of Merck-Medco Managed Care from 1994 to 1996. Mr. Benito has been a Director of Inovio Pharmaceuticals, Inc. since December 18, 2003. Mr. Benito has been a Director of DURECT Corporation since April 18, 2005. ...

Read Full Background

Corporate Headquarters*

660 West Germantown Pike
Plymouth Meeting, Pennsylvania 19462

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships*

2003-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2005-Present
Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$75,000
Total Calculated Compensation$144,835
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INO:US $8.37 USD +0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Corporate Secretary and Director
GenVec, Inc.
$375.0K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$557.7K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$515.0K
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$393.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.